Amneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Beats Estimates By $0.03 EPS

Amneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Beats Estimates By $0.03 EPS

Amneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.03. Amneal Pharmaceuticals had a net margin of 5.05% and a negative return on equity of 584.46%. The company had revenue of $862.68 million during the quarter.